These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 26988593)
1. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies. Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593 [TBL] [Abstract][Full Text] [Related]
2. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population. Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368 [TBL] [Abstract][Full Text] [Related]
3. The genetic effects of hormones modulated by the Pituitary-Thyroid/Adrenal/Gonadal axis on the risk of developing venous thromboembolism: a mendelian randomization study. Tian H; Xie C; Teng B; Zeng Q; Zhao Y; Li F; Jiang C; Chen Z BMC Cardiovasc Disord; 2024 Jul; 24(1):383. PubMed ID: 39054435 [TBL] [Abstract][Full Text] [Related]
4. YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies. Kjaergaard AD; Bojesen SE; Nordestgaard BG; Johansen JS Clin Chem; 2014 Nov; 60(11):1429-40. PubMed ID: 25225167 [TBL] [Abstract][Full Text] [Related]
5. Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population. Kjaergaard AD; Nordestgaard BG; Johansen JS; Bojesen SE Int J Cancer; 2015 Dec; 137(11):2696-704. PubMed ID: 26095694 [TBL] [Abstract][Full Text] [Related]
7. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. Klovaite J; Benn M; Nordestgaard BG J Intern Med; 2015 May; 277(5):573-84. PubMed ID: 25161014 [TBL] [Abstract][Full Text] [Related]
8. Statins and risk of venous thromboembolic diseases: A two-sample mendelian randomization study. Ma XS; Sun J; Geng R; Zhao Y; Xu WZ; Liu YH; Jiang YN; Li YQ Nutr Metab Cardiovasc Dis; 2023 May; 33(5):1087-1092. PubMed ID: 36958971 [TBL] [Abstract][Full Text] [Related]
9. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies. Zeng J; Zeng Q Eur J Prev Cardiol; 2019 Jan; 26(2):120-134. PubMed ID: 30466296 [TBL] [Abstract][Full Text] [Related]
10. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population. Kjaergaard AD; Helby J; Johansen JS; Nordestgaard BG; Bojesen SE Clin Microbiol Infect; 2020 Oct; 26(10):1411.e1-1411.e9. PubMed ID: 31972315 [TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study. Wang CC; Lin CL; Wang GJ; Chang CT; Sung FC; Kao CH Thromb Haemost; 2015 Jan; 113(1):185-92. PubMed ID: 25318828 [TBL] [Abstract][Full Text] [Related]
12. Associations between genetically predicted TIMP-3 levels and risk of venous thromboembolism: A two sample Mendelian randomization study. Li Y; Wang X; Zhang X; Chen Q; Shi X; Zhang B; Xu J; Han B J Pharm Biomed Anal; 2024 Sep; 248():116290. PubMed ID: 38878456 [TBL] [Abstract][Full Text] [Related]
13. Evidence for causal effects of neuropsychiatric conditions on risk of venous thromboembolism: A univariable and multivariable Mendelian randomization study. Jing N; Gao X; Ding H; Wang Y; Zhang Y; Liang G; Gao M J Vasc Surg Venous Lymphat Disord; 2024 Nov; 12(6):101889. PubMed ID: 38621580 [TBL] [Abstract][Full Text] [Related]
14. Circulating Cytokines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study. Hu T; Su P; Yang F; Ying J; Chen Y; Cui H Thromb Haemost; 2024 May; 124(5):471-481. PubMed ID: 38109907 [TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Juul K; Tybjaerg-Hansen A; Schnohr P; Nordestgaard BG Ann Intern Med; 2004 Mar; 140(5):330-7. PubMed ID: 14996674 [TBL] [Abstract][Full Text] [Related]
16. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism? Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173 [No Abstract] [Full Text] [Related]
17. Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study. Sundbøll J; Hováth-Puhó E; Adelborg K; Ording A; Schmidt M; Bøtker HE; Sørensen HT Int J Cardiol; 2017 Aug; 241():182-187. PubMed ID: 28473169 [TBL] [Abstract][Full Text] [Related]
18. Increased rheumatoid factor and deep venous thrombosis: 2 cohort studies of 54628 individuals from the general population. Meyer-Olesen CL; Nielsen SF; Nordestgaard BG Clin Chem; 2015 Feb; 61(2):349-59. PubMed ID: 25278501 [TBL] [Abstract][Full Text] [Related]
19. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study. Warny M; Helby J; Birgens HS; Bojesen SE; Nordestgaard BG J Thromb Haemost; 2019 Nov; 17(11):1898-1911. PubMed ID: 31309714 [TBL] [Abstract][Full Text] [Related]
20. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis. Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]